Close

Roth Capital Upgrades Applied Genetic Technologies Corp. (AGTC) to Buy

Go back to Roth Capital Upgrades Applied Genetic Technologies Corp. (AGTC) to Buy

Applied Genetic Technologies (AGTC) Tops Q1 EPS by 28c

November 8, 2016 4:14 PM EST

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of $0.20, $0.28 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $10.21 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

... More